{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:49:08Z","timestamp":1790725748896,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["COVID1903010"],"award-info":[{"award-number":["COVID1903010"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["17119820"],"award-info":[{"award-number":["17119820"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.virusres.2024.199371","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T16:58:33Z","timestamp":1713459513000},"page":"199371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitro"],"prefix":"10.1016","volume":"345","author":[{"given":"Danlei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Yi","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi-Yan","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok-Hung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1556-2538","authenticated-orcid":false,"given":"Ivan Fan-Ngai","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.virusres.2024.199371_bib0001","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1038\/s41467-021-26113-1","article-title":"Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity","volume":"12","author":"Achdout","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.virusres.2024.199371_bib0002","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/jmv.27588","article-title":"Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines","volume":"94","author":"Araf","year":"2022","journal-title":"J. Med. Virol."},{"issue":"10","key":"10.1016\/j.virusres.2024.199371_bib0003","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3390\/v12101139","article-title":"In vitro combinations of baloxavir acid and other inhibitors against seasonal influenza A viruses","volume":"12","author":"Checkmahomed","year":"2020","journal-title":"Viruses"},{"issue":"15","key":"10.1016\/j.virusres.2024.199371_bib0004","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.virusres.2024.199371_bib0005","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/jmv.26014","article-title":"Co-infection with COVID-19 and influenza A virus in two died patients with acute respiratory syndrome, Bojnurd, Iran","volume":"92","author":"Hashemi","year":"2020","journal-title":"J. Med. Virol."},{"issue":"10","key":"10.1016\/j.virusres.2024.199371_bib0006","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"66","key":"10.1016\/j.virusres.2024.199371_bib0007","doi-asserted-by":"crossref","first-page":"eabm3131","DOI":"10.1126\/sciimmunol.abm3131","article-title":"Immune memory from SARS-CoV-2 infection in hamsters provides variant-independent protection but still allows virus transmission","volume":"6","author":"Horiuchi","year":"2021","journal-title":"Sci. Immunol."},{"issue":"10","key":"10.1016\/j.virusres.2024.199371_bib0008","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S1473-3099(20)30004-9","article-title":"Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Ison","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"9","key":"10.1016\/j.virusres.2024.199371_bib0009","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"20","key":"10.1016\/j.virusres.2024.199371_bib0010","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1001\/jama.2020.6266","article-title":"Rates of Co-infection between SARS-CoV-2 and other respiratory pathogens","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.virusres.2024.199371_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21111513","article-title":"Influenza neuraminidase inhibitors: synthetic approaches, derivatives and biological activity","volume":"21","author":"Laborda","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.virusres.2024.199371_bib0012","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.antiviral.2018.07.001","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017","volume":"157","author":"Lackenby","year":"2018","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.virusres.2024.199371_bib0013","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","article-title":"Co-infections in people with COVID-19: a systematic review and meta-analysis","volume":"81","author":"Lansbury","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.virusres.2024.199371_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130152","article-title":"Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: an extensive study","volume":"1234","author":"Mandal","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.virusres.2024.199371_bib0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.virol.2015.05.021","article-title":"Interaction between unrelated viruses during in vivo co-infection to limit pathology and immunity","volume":"484","author":"McAfee","year":"2015","journal-title":"Virology"},{"issue":"10335","key":"10.1016\/j.virusres.2024.199371_bib0016","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","article-title":"Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study","volume":"399","author":"Menni","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2024.199371_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104545","article-title":"Antivirals targeting the polymerase complex of influenza viruses","volume":"169","author":"Mifsud","year":"2019","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.virusres.2024.199371_bib0018","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1093\/cid\/ciac443","article-title":"Effectiveness of paxlovid in reducing severe COVID-19 and mortality in high risk patients","volume":"76","author":"Najjar-Debbiny","year":"2022","journal-title":"Clin. Infect. Dis."},{"issue":"15","key":"10.1016\/j.virusres.2024.199371_bib0019","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00765-22","article-title":"The host response to influenza A virus interferes with SARS-CoV-2 replication during coinfection","volume":"96","author":"Oishi","year":"2022","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2024.199371_bib0020","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for Covid-19 - interim WHO solidarity trial results","volume":"384","author":"Pan","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.virusres.2024.199371_bib0021","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/cid\/ciac180","article-title":"Molnupiravir and nirmatrelvir-ritonavir: oral coronavirus disease 2019 antiviral drugs","volume":"76","author":"Saravolatz","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.virusres.2024.199371_bib0022","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/ije\/dyab081","article-title":"Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design","volume":"50","author":"Stowe","year":"2021","journal-title":"Int. J. Epidemiol."},{"issue":"10334","key":"10.1016\/j.virusres.2024.199371_bib0023","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(22)00383-X","article-title":"SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses","volume":"399","author":"Swets","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.virusres.2024.199371_bib0024","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3201\/eid2606.200299","article-title":"Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China","volume":"26","author":"Wu","year":"2020","journal-title":"Emerg. Infect. Dis."},{"issue":"12","key":"10.1016\/j.virusres.2024.199371_bib0025","doi-asserted-by":"crossref","first-page":"e978","DOI":"10.1093\/cid\/ciaa1747","article-title":"Coinfection by severe acute respiratory syndrome Coronavirus 2 and influenza A(H1N1)pdm09 virus enhances the severity of pneumonia in golden syrian hamsters","volume":"72","author":"Zhang","year":"2021","journal-title":"Clin. Infect. Dis."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170224000649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170224000649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:29:06Z","timestamp":1777508946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170224000649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":25,"alternative-id":["S0168170224000649"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2024.199371","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitro","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2024.199371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199371"}}